Compile Data Set for Download or QSAR
Report error Found 44 Enz. Inhib. hit(s) with all data for entry = 13217
TargetPoly [ADP-ribose] polymerase 1(Human)
Xuanzhu Biopharmaceutical Co.

US Patent
LigandPNGBDBM767564(6-fluoro-N-methyl-5-(4-((3-methyl-2-oxo-1,2,4,5-te...)
Affinity DataIC50: 1nMAssay Description:1) 10 μL of LDNA solution was added into a negative control well, 10 μL of PARP1& DNA (or PARP2& DNA) mixed solution was added into wells excluding t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Xuanzhu Biopharmaceutical Co.

US Patent
LigandPNGBDBM767569(US20250270224, Compound 41-1)
Affinity DataIC50: 1nMAssay Description:1) 10 μL of LDNA solution was added into a negative control well, 10 μL of PARP1& DNA (or PARP2& DNA) mixed solution was added into wells excluding t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Xuanzhu Biopharmaceutical Co.

US Patent
LigandPNGBDBM767570(US20250270224, Compound 41-2)
Affinity DataIC50: 1nMAssay Description:1) 10 μL of LDNA solution was added into a negative control well, 10 μL of PARP1& DNA (or PARP2& DNA) mixed solution was added into wells excluding t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Xuanzhu Biopharmaceutical Co.

US Patent
LigandPNGBDBM767575((S)-6-fluoro-N-methyl-5-(4-((3-methyl-2-oxo-2,3-di...)
Affinity DataIC50: 1nMAssay Description:1) 10 μL of LDNA solution was added into a negative control well, 10 μL of PARP1& DNA (or PARP2& DNA) mixed solution was added into wells excluding t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Xuanzhu Biopharmaceutical Co.

US Patent
LigandPNGBDBM767576((R)-6-fluoro-5-(4-((9-fluoro-3-methyl-2-oxo-2,3-di...)
Affinity DataIC50: 1nMAssay Description:1) 10 μL of LDNA solution was added into a negative control well, 10 μL of PARP1& DNA (or PARP2& DNA) mixed solution was added into wells excluding t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Xuanzhu Biopharmaceutical Co.

US Patent
LigandPNGBDBM767560(6-fluoro-N-methyl-5-(4-((3-methyl-2-oxo-2,4,5,6-te...)
Affinity DataIC50: 1nMAssay Description:1) 10 μL of LDNA solution was added into a negative control well, 10 μL of PARP1& DNA (or PARP2& DNA) mixed solution was added into wells excluding t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Xuanzhu Biopharmaceutical Co.

US Patent
LigandPNGBDBM767573((R)-6-fluoro-5-(4-((6-fluoro-3-methyl-2-oxo-2,3-di...)
Affinity DataIC50: 1nMAssay Description:1) 10 μL of LDNA solution was added into a negative control well, 10 μL of PARP1& DNA (or PARP2& DNA) mixed solution was added into wells excluding t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Xuanzhu Biopharmaceutical Co.

US Patent
LigandPNGBDBM767566((S)-6-fluoro-5-(4-((9-fluoro-3-methyl-2-oxo-2,3-di...)
Affinity DataIC50: 1nMAssay Description:1) 10 μL of LDNA solution was added into a negative control well, 10 μL of PARP1& DNA (or PARP2& DNA) mixed solution was added into wells excluding t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Xuanzhu Biopharmaceutical Co.

US Patent
LigandPNGBDBM767574((R)-6-fluoro-N-methyl-5-(4-((3-methyl-2-oxo-2,3-di...)
Affinity DataIC50: 1nMAssay Description:1) 10 μL of LDNA solution was added into a negative control well, 10 μL of PARP1& DNA (or PARP2& DNA) mixed solution was added into wells excluding t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Xuanzhu Biopharmaceutical Co.

US Patent
LigandPNGBDBM767579(US20250270224, Compound 38-1)
Affinity DataIC50: 2nMAssay Description:1) 10 μL of LDNA solution was added into a negative control well, 10 μL of PARP1& DNA (or PARP2& DNA) mixed solution was added into wells excluding t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Xuanzhu Biopharmaceutical Co.

US Patent
LigandPNGBDBM767563((S)-6-fluoro-N-methyl-5-(4-((3-methyl-2-oxo-2,3-di...)
Affinity DataIC50: 2nMAssay Description:1) 10 μL of LDNA solution was added into a negative control well, 10 μL of PARP1& DNA (or PARP2& DNA) mixed solution was added into wells excluding t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Xuanzhu Biopharmaceutical Co.

US Patent
LigandPNGBDBM767572((S)-6-fluoro-5-(4-((6-fluoro-3-methyl-2-oxo-2,3-di...)
Affinity DataIC50: 2nMAssay Description:1) 10 μL of LDNA solution was added into a negative control well, 10 μL of PARP1& DNA (or PARP2& DNA) mixed solution was added into wells excluding t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Xuanzhu Biopharmaceutical Co.

US Patent
LigandPNGBDBM767580(US20250270224, Compound 38-2)
Affinity DataIC50: 2nMAssay Description:1) 10 μL of LDNA solution was added into a negative control well, 10 μL of PARP1& DNA (or PARP2& DNA) mixed solution was added into wells excluding t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Xuanzhu Biopharmaceutical Co.

US Patent
LigandPNGBDBM767577((R)-6-fluoro-N-methyl-5-(4-((4-methyl-5-oxo-5,6-di...)
Affinity DataIC50: 2nMAssay Description:1) 10 μL of LDNA solution was added into a negative control well, 10 μL of PARP1& DNA (or PARP2& DNA) mixed solution was added into wells excluding t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Xuanzhu Biopharmaceutical Co.

US Patent
LigandPNGBDBM767561(6-fluoro-N-methyl-5-(4-((3-methyl-2-oxo-2,3-dihydr...)
Affinity DataIC50: 2nMAssay Description:1) 10 μL of LDNA solution was added into a negative control well, 10 μL of PARP1& DNA (or PARP2& DNA) mixed solution was added into wells excluding t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Xuanzhu Biopharmaceutical Co.

US Patent
LigandPNGBDBM767578((S)-6-fluoro-N-methyl-5-(4-((4-methyl-5-oxo-5,6-di...)
Affinity DataIC50: 2nMAssay Description:1) 10 μL of LDNA solution was added into a negative control well, 10 μL of PARP1& DNA (or PARP2& DNA) mixed solution was added into wells excluding t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Xuanzhu Biopharmaceutical Co.

US Patent
LigandPNGBDBM767562((R)-6-fluoro-N-methyl-5-(4-((3-methyl-2-oxo-2,3-di...)
Affinity DataIC50: 2nMAssay Description:1) 10 μL of LDNA solution was added into a negative control well, 10 μL of PARP1& DNA (or PARP2& DNA) mixed solution was added into wells excluding t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Xuanzhu Biopharmaceutical Co.

US Patent
LigandPNGBDBM767567((R)-6-fluoro-5-(4-((9-fluoro-3-methyl-2-oxo-2,3-di...)
Affinity DataIC50: 2nMAssay Description:1) 10 μL of LDNA solution was added into a negative control well, 10 μL of PARP1& DNA (or PARP2& DNA) mixed solution was added into wells excluding t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Xuanzhu Biopharmaceutical Co.

US Patent
LigandPNGBDBM767455(6-fluoro-5-(4-((9-fluoro-3-methyl-2-oxo-2,3-dihydr...)
Affinity DataIC50: 2nMAssay Description:1) 10 μL of LDNA solution was added into a negative control well, 10 μL of PARP1& DNA (or PARP2& DNA) mixed solution was added into wells excluding t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Xuanzhu Biopharmaceutical Co.

US Patent
LigandPNGBDBM767568(US20250270224, Compound 38)
Affinity DataIC50: 2nMAssay Description:1) 10 μL of LDNA solution was added into a negative control well, 10 μL of PARP1& DNA (or PARP2& DNA) mixed solution was added into wells excluding t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Xuanzhu Biopharmaceutical Co.

US Patent
LigandPNGBDBM767565(6-fluoro-5-(4-((9-fluoro-3,5-dimethyl-2-oxo-2,3-di...)
Affinity DataIC50: 2nMAssay Description:1) 10 μL of LDNA solution was added into a negative control well, 10 μL of PARP1& DNA (or PARP2& DNA) mixed solution was added into wells excluding t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Xuanzhu Biopharmaceutical Co.

US Patent
LigandPNGBDBM767571(5-(4-((3,3-dimethyl-2-oxo-2,3-dihydro-1H-pyrrolo[1...)
Affinity DataIC50: 6.5nMAssay Description:1) 10 μL of LDNA solution was added into a negative control well, 10 μL of PARP1& DNA (or PARP2& DNA) mixed solution was added into wells excluding t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Xuanzhu Biopharmaceutical Co.

US Patent
LigandPNGBDBM767560(6-fluoro-N-methyl-5-(4-((3-methyl-2-oxo-2,4,5,6-te...)
Affinity DataIC50: 55nMAssay Description:1) 10 μL of LDNA solution was added into a negative control well, 10 μL of PARP1& DNA (or PARP2& DNA) mixed solution was added into wells excluding t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Xuanzhu Biopharmaceutical Co.

US Patent
LigandPNGBDBM767564(6-fluoro-N-methyl-5-(4-((3-methyl-2-oxo-1,2,4,5-te...)
Affinity DataIC50: 55nMAssay Description:1) 10 μL of LDNA solution was added into a negative control well, 10 μL of PARP1& DNA (or PARP2& DNA) mixed solution was added into wells excluding t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Xuanzhu Biopharmaceutical Co.

US Patent
LigandPNGBDBM767570(US20250270224, Compound 41-2)
Affinity DataIC50: 550nMAssay Description:1) 10 μL of LDNA solution was added into a negative control well, 10 μL of PARP1& DNA (or PARP2& DNA) mixed solution was added into wells excluding t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Xuanzhu Biopharmaceutical Co.

US Patent
LigandPNGBDBM767571(5-(4-((3,3-dimethyl-2-oxo-2,3-dihydro-1H-pyrrolo[1...)
Affinity DataIC50: 550nMAssay Description:1) 10 μL of LDNA solution was added into a negative control well, 10 μL of PARP1& DNA (or PARP2& DNA) mixed solution was added into wells excluding t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Xuanzhu Biopharmaceutical Co.

US Patent
LigandPNGBDBM767568(US20250270224, Compound 38)
Affinity DataIC50: 550nMAssay Description:1) 10 μL of LDNA solution was added into a negative control well, 10 μL of PARP1& DNA (or PARP2& DNA) mixed solution was added into wells excluding t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Xuanzhu Biopharmaceutical Co.

US Patent
LigandPNGBDBM767569(US20250270224, Compound 41-1)
Affinity DataIC50: 550nMAssay Description:1) 10 μL of LDNA solution was added into a negative control well, 10 μL of PARP1& DNA (or PARP2& DNA) mixed solution was added into wells excluding t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Xuanzhu Biopharmaceutical Co.

US Patent
LigandPNGBDBM767580(US20250270224, Compound 38-2)
Affinity DataIC50: 550nMAssay Description:1) 10 μL of LDNA solution was added into a negative control well, 10 μL of PARP1& DNA (or PARP2& DNA) mixed solution was added into wells excluding t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Xuanzhu Biopharmaceutical Co.

US Patent
LigandPNGBDBM767565(6-fluoro-5-(4-((9-fluoro-3,5-dimethyl-2-oxo-2,3-di...)
Affinity DataIC50: 550nMAssay Description:1) 10 μL of LDNA solution was added into a negative control well, 10 μL of PARP1& DNA (or PARP2& DNA) mixed solution was added into wells excluding t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Xuanzhu Biopharmaceutical Co.

US Patent
LigandPNGBDBM767562((R)-6-fluoro-N-methyl-5-(4-((3-methyl-2-oxo-2,3-di...)
Affinity DataIC50: 550nMAssay Description:1) 10 μL of LDNA solution was added into a negative control well, 10 μL of PARP1& DNA (or PARP2& DNA) mixed solution was added into wells excluding t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Xuanzhu Biopharmaceutical Co.

US Patent
LigandPNGBDBM767579(US20250270224, Compound 38-1)
Affinity DataIC50: 550nMAssay Description:1) 10 μL of LDNA solution was added into a negative control well, 10 μL of PARP1& DNA (or PARP2& DNA) mixed solution was added into wells excluding t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Xuanzhu Biopharmaceutical Co.

US Patent
LigandPNGBDBM767563((S)-6-fluoro-N-methyl-5-(4-((3-methyl-2-oxo-2,3-di...)
Affinity DataIC50: 550nMAssay Description:1) 10 μL of LDNA solution was added into a negative control well, 10 μL of PARP1& DNA (or PARP2& DNA) mixed solution was added into wells excluding t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Xuanzhu Biopharmaceutical Co.

US Patent
LigandPNGBDBM767576((R)-6-fluoro-5-(4-((9-fluoro-3-methyl-2-oxo-2,3-di...)
Affinity DataIC50: 550nMAssay Description:1) 10 μL of LDNA solution was added into a negative control well, 10 μL of PARP1& DNA (or PARP2& DNA) mixed solution was added into wells excluding t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Xuanzhu Biopharmaceutical Co.

US Patent
LigandPNGBDBM767561(6-fluoro-N-methyl-5-(4-((3-methyl-2-oxo-2,3-dihydr...)
Affinity DataIC50: 550nMAssay Description:1) 10 μL of LDNA solution was added into a negative control well, 10 μL of PARP1& DNA (or PARP2& DNA) mixed solution was added into wells excluding t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Xuanzhu Biopharmaceutical Co.

US Patent
LigandPNGBDBM767574((R)-6-fluoro-N-methyl-5-(4-((3-methyl-2-oxo-2,3-di...)
Affinity DataIC50: 550nMAssay Description:1) 10 μL of LDNA solution was added into a negative control well, 10 μL of PARP1& DNA (or PARP2& DNA) mixed solution was added into wells excluding t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Xuanzhu Biopharmaceutical Co.

US Patent
LigandPNGBDBM767575((S)-6-fluoro-N-methyl-5-(4-((3-methyl-2-oxo-2,3-di...)
Affinity DataIC50: 550nMAssay Description:1) 10 μL of LDNA solution was added into a negative control well, 10 μL of PARP1& DNA (or PARP2& DNA) mixed solution was added into wells excluding t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Xuanzhu Biopharmaceutical Co.

US Patent
LigandPNGBDBM767572((S)-6-fluoro-5-(4-((6-fluoro-3-methyl-2-oxo-2,3-di...)
Affinity DataIC50: 550nMAssay Description:1) 10 μL of LDNA solution was added into a negative control well, 10 μL of PARP1& DNA (or PARP2& DNA) mixed solution was added into wells excluding t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Xuanzhu Biopharmaceutical Co.

US Patent
LigandPNGBDBM767573((R)-6-fluoro-5-(4-((6-fluoro-3-methyl-2-oxo-2,3-di...)
Affinity DataIC50: 550nMAssay Description:1) 10 μL of LDNA solution was added into a negative control well, 10 μL of PARP1& DNA (or PARP2& DNA) mixed solution was added into wells excluding t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Xuanzhu Biopharmaceutical Co.

US Patent
LigandPNGBDBM767578((S)-6-fluoro-N-methyl-5-(4-((4-methyl-5-oxo-5,6-di...)
Affinity DataIC50: 1.00E+3nMAssay Description:1) 10 μL of LDNA solution was added into a negative control well, 10 μL of PARP1& DNA (or PARP2& DNA) mixed solution was added into wells excluding t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Xuanzhu Biopharmaceutical Co.

US Patent
LigandPNGBDBM767577((R)-6-fluoro-N-methyl-5-(4-((4-methyl-5-oxo-5,6-di...)
Affinity DataIC50: 1.00E+3nMAssay Description:1) 10 μL of LDNA solution was added into a negative control well, 10 μL of PARP1& DNA (or PARP2& DNA) mixed solution was added into wells excluding t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Xuanzhu Biopharmaceutical Co.

US Patent
LigandPNGBDBM767566((S)-6-fluoro-5-(4-((9-fluoro-3-methyl-2-oxo-2,3-di...)
Affinity DataIC50: 1.00E+3nMAssay Description:1) 10 μL of LDNA solution was added into a negative control well, 10 μL of PARP1& DNA (or PARP2& DNA) mixed solution was added into wells excluding t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Xuanzhu Biopharmaceutical Co.

US Patent
LigandPNGBDBM767567((R)-6-fluoro-5-(4-((9-fluoro-3-methyl-2-oxo-2,3-di...)
Affinity DataIC50: 1.00E+3nMAssay Description:1) 10 μL of LDNA solution was added into a negative control well, 10 μL of PARP1& DNA (or PARP2& DNA) mixed solution was added into wells excluding t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Xuanzhu Biopharmaceutical Co.

US Patent
LigandPNGBDBM767455(6-fluoro-5-(4-((9-fluoro-3-methyl-2-oxo-2,3-dihydr...)
Affinity DataIC50: 1.00E+3nMAssay Description:1) 10 μL of LDNA solution was added into a negative control well, 10 μL of PARP1& DNA (or PARP2& DNA) mixed solution was added into wells excluding t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent